Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
281
-
Total 13F shares, excl. options
-
65.3M
-
Shares change
-
-1.73M
-
Total reported value, excl. options
-
$4.96B
-
Value change
-
-$130M
-
Number of buys
-
134
-
Number of sells
-
-123
-
Price
-
$75.88
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2016
297 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2016.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 281 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.3M shares
of 71.9M outstanding shares and own 90.73% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (8.96M shares), VANGUARD GROUP INC (5.71M shares), Neuberger Berman Group LLC (4.24M shares), FRANKLIN RESOURCES INC (3.96M shares), BlackRock Fund Advisors (2.59M shares), STATE STREET CORP (2.53M shares), BlackRock Institutional Trust Company, N.A. (2.3M shares), BAMCO INC /NY/ (2.27M shares), Select Equity Group, L.P. (2.01M shares), and JPMORGAN CHASE & CO (1.27M shares).
This table shows the top 281 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.